Pregnancy in B-cell-deficient mice: postpartum transfer of immunoglobulins prevents neonatal runting and death.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 7888494)

Published in Biol Reprod on December 01, 1994

Authors

E Gustafsson1, A Mattsson, R Holmdahl, R Mattsson

Author Affiliations

1: Department of Animal Development and Genetics, Uppsala University, Sweden.

Articles by these authors

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst (1991) 2.80

Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56

Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet (1989) 2.46

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. J Natl Cancer Inst (1993) 2.38

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol (1995) 2.29

B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol (1998) 2.27

Leukaemia incidence after iodine-131 exposure. Lancet (1992) 2.05

T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol (1985) 1.96

Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum (1986) 1.90

Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol (1985) 1.89

Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol (1997) 1.86

A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Nat Genet (1996) 1.81

Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol (1996) 1.78

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis (2008) 1.71

Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58

Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun (1991) 1.57

Child psychiatric emergencies. Clinical characteristics and follow-up results. Arch Gen Psychiatry (1967) 1.57

The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol (2001) 1.56

The 5' flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer-promoter communication. Curr Biol (2000) 1.55

High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics (1986) 1.49

T cell recognition of carbohydrates on type II collagen. J Exp Med (1994) 1.46

Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol (1994) 1.44

Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum (1988) 1.44

Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res (1998) 1.39

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38

Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum (1986) 1.37

Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol (2000) 1.36

Genistein as an anti-inflammatory agent. Inflamm Res (2003) 1.35

IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J Immunol (2001) 1.32

Clonal expansion of T lymphocytes causes arthritis and mortality in mice infected with toxic shock syndrome toxin-1-producing staphylococci. Eur J Immunol (1994) 1.32

Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res (1998) 1.31

Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol (1994) 1.31

Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol (1992) 1.29

Mice with the xid B cell defect are less susceptible to developing Staphylococcus aureus-induced arthritis. J Immunol (1995) 1.28

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin Exp Immunol (1996) 1.27

Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin Exp Immunol (1990) 1.26

Genes on the X chromosome affect development of collagen-induced arthritis in mice. Clin Exp Immunol (1993) 1.26

Role of T lymphocytes in murine collagen induced arthritis. Agents Actions (1986) 1.24

Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol (1991) 1.24

Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum (1990) 1.23

Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev (1996) 1.23

A novel NOD-derived murine model of primary Sjögren's syndrome. Arthritis Rheum (1998) 1.22

Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol (1990) 1.22

Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol (1998) 1.21

Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol (1996) 1.20

In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20

Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol (1994) 1.19

Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group. Acta Oncol (1992) 1.19

IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice. J Immunol (1999) 1.18

Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes (2001) 1.17

Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat Res (1999) 1.17

Sialadenitis in the MRL-l mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology (1987) 1.17

A rapid and efficient immunization protocol for production of monoclonal antibodies reactive with autoantigens. J Immunol Methods (1985) 1.17

Genetic control of collagen-induced arthritis in a cross with NOD and C57BL/10 mice is dependent on gene regions encoding complement factor 5 and FcgammaRIIb and is not associated with loci controlling diabetes. Eur J Immunol (2001) 1.16

Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis. Clin Exp Immunol (1991) 1.15

In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology (1985) 1.15

Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet (1995) 1.15

Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology (1989) 1.15

Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet (1998) 1.14

Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol (1992) 1.14

Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. Int Immunol (1999) 1.13

Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol (1998) 1.12

Reactivity of monoclonal anti-type II collagen antibodies with cartilage and synovial tissue in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1986) 1.12

Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol (1998) 1.11

Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10

Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol (1995) 1.09

Immunopathological features of rat Staphylococcus aureus arthritis. Infect Immun (1994) 1.08

Long-term physical illness in childhood: a challenge to psychosocial adaptation. Pediatrics (1972) 1.08

Hypervariable allelic expression patterns of the imprinted IGF2 gene in tumor cells. Oncogene (1998) 1.08

Infections with Francisella tularensis biovar palaearctica in hares (Lepus timidus, Lepus europaeus) from Sweden. J Wildl Dis (1988) 1.07

Generation of monoclonal rheumatoid factors after immunization with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol (1986) 1.07

Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reprod Immunol (1989) 1.06

Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat (1998) 1.06

Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci U S A (1987) 1.06

Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol (1995) 1.05

Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis. Ann Rheum Dis (2004) 1.05

Administration of antibodies to hyaluronanreceptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand J Immunol (1995) 1.05

Minimal eating observation form: reliability and validity. J Nutr Health Aging (2009) 1.04

The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol (1998) 1.04

Characterization of a spontaneously occurring arthritis in male DBA/1 mice. Arthritis Rheum (1992) 1.04

Host defense against cholera toxin is strongly CD4+ T cell dependent. Infect Immun (1991) 1.03

Gamma-interferon-like immunoreactivity in axotomized rat motor neurons. J Neurosci (1989) 1.03

Evaluation of the percentage of peripheral T cells with two different T cell receptor alpha-chains and of their potential role in autoimmunity. J Autoimmun (2001) 1.02

Patterns of autoreactivity to collagen type II in autoimmune MRL/l mice. Clin Exp Immunol (1986) 1.02

T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum (2000) 1.02

Appearance of different lymphoid cells in synovial tissue and in peripheral blood during the course of collagen II-induced arthritis in rats. Scand J Immunol (1985) 1.01

Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum (2001) 1.01

Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin Exp Immunol (2003) 1.01

Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation. Proc Natl Acad Sci U S A (1999) 1.00

Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice. Immunology (1991) 1.00

Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur J Immunol (1996) 1.00

T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse. Immunology (1991) 0.97

Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology (1989) 0.97

Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem (1998) 0.97

Mechanism of phytohemagglutinin (PHA) action. IV. Effect of some metabolic inhibitors on binding of PHA to lymphocytes and the stimulatory potential of PHA-pretreated cells. Exp Cell Res (1971) 0.97